A detailed history of Fora Capital, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 47,869 shares of ARDX stock, worth $187,646. This represents 0.03% of its overall portfolio holdings.

Number of Shares
47,869
Holding current value
$187,646
% of portfolio
0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$4.91 - $6.36 $235,036 - $304,446
47,869 New
47,869 $235,000
Q1 2021

May 17, 2021

SELL
$6.1 - $7.69 $16,793 - $21,170
-2,753 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$5.05 - $7.1 $13,902 - $19,546
2,753 New
2,753 $17,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $606M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.